ahlam1399
09-09-2015, 04:11 AM
UPDATE 1-Independent group finds new cholesterol ***** far too costly
Sept 8 (Reuters) - An independent **n-profit organization that evaluates clinical and cost effectiveness of new medicines said an**unced prices for a just-approved class of potent cholesterol lowering ***** were far too high, according to a draft report released on Tuesday.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49ad905a/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=STupkOAkGsU:bbdnE1u3Ijo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=STupkOAkGsU:bbdnE1u3Ijo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=STupkOAkGsU:bbdnE1u3Ijo:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=STupkOAkGsU:bbdnE1u3Ijo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=STupkOAkGsU:bbdnE1u3Ijo:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/STupkOAkGsU
Sept 8 (Reuters) - An independent **n-profit organization that evaluates clinical and cost effectiveness of new medicines said an**unced prices for a just-approved class of potent cholesterol lowering ***** were far too high, according to a draft report released on Tuesday.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49ad905a/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=STupkOAkGsU:bbdnE1u3Ijo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=STupkOAkGsU:bbdnE1u3Ijo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=STupkOAkGsU:bbdnE1u3Ijo:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=STupkOAkGsU:bbdnE1u3Ijo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=STupkOAkGsU:bbdnE1u3Ijo:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/STupkOAkGsU